These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 8308768

  • 1. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D.
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ, Beal J, Day RO, Tett SE.
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [Abstract] [Full Text] [Related]

  • 6. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM, Sandhu S, Lochhead A, Hurst NP, McRorie E, Dhillon V.
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of an easily prepared solution of injectable methotrexate diluted in water: A comparison of serum concentrations vs methotrexate tablets and clinical utility.
    Marshall PS, Gertner E.
    J Rheumatol; 1996 Mar; 23(3):455-8. PubMed ID: 8832982
    [Abstract] [Full Text] [Related]

  • 8. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G, Angeles-Moreno AP, Contreras-Zavala L, Morales-Martínez M, Rivera-Espinosa L.
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [Abstract] [Full Text] [Related]

  • 9. A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis.
    Westhovens R, Houssiau F, Joly J, Everitt DE, Zhu Y, Sisco D, Van Hartingsveldt B, Mascelli MA, Graham MA, Durez P, Bouman-Thio E.
    J Rheumatol; 2006 May; 33(5):847-53. PubMed ID: 16583466
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M.
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [Abstract] [Full Text] [Related]

  • 11. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
    Hatorp V, Oliver S, Su CA.
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
    [Abstract] [Full Text] [Related]

  • 12. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M, Tempero K, Kirby M, Thompson J.
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [Abstract] [Full Text] [Related]

  • 13. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S, Lafforgue P, Blanc A, Catalin J, Aquaviva PC, Durand A.
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR.
    Cancer Treat Rep; 1985 Jul; 69(7-8):833-8. PubMed ID: 3893694
    [Abstract] [Full Text] [Related]

  • 15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 16. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM, Petrillo GF, Hamilton RA.
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [Abstract] [Full Text] [Related]

  • 17. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam: relative bioavailability and bioequivalence of a 10% oral solution (750 mg) and 750-mg tablets.
    Coupez R, Straetemans R, Sehgal G, Stockis A, Lu ZS.
    J Clin Pharmacol; 2003 Dec; 43(12):1370-6. PubMed ID: 14615473
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic profiles for oral and subcutaneous methotrexate in patients with Crohn's disease.
    Wilson A, Patel V, Chande N, Ponich T, Urquhart B, Asher L, Choi Y, Tirona R, Kim RB, Gregor JC.
    Aliment Pharmacol Ther; 2013 Feb; 37(3):340-5. PubMed ID: 23190184
    [Abstract] [Full Text] [Related]

  • 20. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U, Heuer KU.
    Clin Exp Rheumatol; 2014 Feb; 32(4):563-71. PubMed ID: 24983446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.